Technology | PET-CT | June 21, 2018

FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems

New features designed to advance clinical capabilities for entire Biograph mCT family of PET/CT systems

FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems

June 21, 2018 — Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for the Biograph mCT family of positron emission tomography/computed tomography (PET/CT) systems at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). These features, three of which are also available on the Biograph Vision PET/CT scanner, bring advanced clinical capabilities to healthcare providers, enabling them to expand precision medicine and transform the delivery of patient care.

The QualityGuard¹ feature self-calibrates the PET detector by tapping natural background radiation from the lutetium oxyorthosilicate (LSO) detectors to run daily and weekly quality control (QC) procedures during off-hours. This saves up to 30 minutes of staff time per day, according to Siemens. Self-calibration eliminates use of a radioactive source for daily and weekly manual calibration, thereby reducing the technologist’s radiation exposure in addition to eliminating the need to lift the radioactive source, which can weigh 25 to 30 lbs.

A second feature, FlowMotion Multiparametric PET Suite, is fully automated and delivers whole-body parametric PET images based on the Patlak reference tissue model. In a single examination and without the need for arterial blood sampling, FlowMotion Multiparametric PET Suite provides images of metabolic rate and distribution volume in addition to standard uptake value (SUV) images. FlowMotion Multiparametric PET Suite reduces the variability of quantitative measurements due to differences in uptake time, patient body size and blood glucose levels. This leads to better characterization of tracer uptake compared to SUV alone.

The OncoFreeze feature provides images that are virtually free of respiratory motion in the same time as a standard whole-body scan. Traditionally, respiratory gated images use only select information from a portion of the patient’s respiratory cycle; the remaining data from the PET/CT scan is discarded. OncoFreeze utilizes 100 percent of acquired information from the respiratory cycle and reduces acquisition time.

Finally, CardioFreeze corrects for respiratory and cardiac motion associated with cardiac PET/CT image acquisitions and can obtain the respiratory waveform just by analyzing PET data. Each cardiac gate is reconstructed with 100 percent of the data acquired. This eliminates variability from cardiac and respiratory motion, and improving visualization of myocardial tracer distribution, wall thickness and defect definition.

For more information: www.usa.healthcare.siemens.com

 

Reference

1. QualityGuard is currently under development on Biograph Vision and is not available for sale in the U.S. or any other country.

Related Content

News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
Figure 1

Figure 1

Feature | Information Technology | November 09, 2018 | By Jef Williams and Laurie Lafleur
Every year in late November tens of thousands of diagnostic imaging professionals from all over the globe descend upon...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
Feature | PET Imaging | November 07, 2018 | By Greg Freiherr
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology....
Podcast | PET Imaging | November 07, 2018
PET is getting ready to venture outside oncology, cardiology and mainstream neurology.